Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) is an enzyme in the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family that initiates mucin-type O-linked glycosylation in the Golgi apparatus by transferring GalNAc to serine and threonine residues of substrate proteins. The enzyme is a type II transmembrane protein consisting of an N-terminal cytoplasmic region, a transmembrane anchor, a stem region, a catalytic GT-A fold domain, and a C-terminal ricin/lectin-like domain. GalNAc-T4 exhibits both short-range and long-range substrate preferences: it preferentially glycosylates serine/threonine residues just C-terminal to a pre-existing N-terminal glycosylated site on the substrate, a specificity determined by its catalytic and lectin domains connected via a flexible linker. The structure and substrate specificity of GalNAc-T4 distinguish it from related transferase isoforms, making it important both for the initial steps of mucin-type O-glycosylation and for the consequent structural and functional diversity of glycoproteins in health and disease. No direct therapeutic agents targeting GalNAc-T4 are approved or in late-stage clinical development, but dysregulation of GalNAc-T4 and related enzymes is widely implicated in cancer and other pathological states.
Catalyzes the transfer of an N-acetylgalactosamine molecule from UDP-GalNAc to the hydroxyl group of a serine or threonine residue in polypeptides. Prefers glycopeptide substrates with an N-terminally glycosylated threonine, recognizes polypeptide sequence and prior glycosylation state through distinct catalytic and lectin domains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4).